by Asthma spacers are medical devices that help children and elderly patients, who have difficulty using pressurized metered-dose inhalers (pMDIs), to properly inhale asthma medications. Asthma spacers attach between a pMDI canister and a patient’s mouth to form a chamber that allows the medication particles to slow down and spread out. This allows more medication to enter the lungs and less dose to be deposited in the mouth or throat. Asthma spacers provide an alternative method to using inhalers for asthma patients.
The Global Asthma Spacers Market is estimated to be valued at US$ 2.15 Bn in 2024 and is expected to exhibit a CAGR of 19% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the Asthma Spacers Market Size include Merck KGaA, Thermo Fisher Scientific, Origene Technologies, Inc., New England Biolabs, GenScript, GeneCopoeia, Inc., Cellecta, Inc., Agilent Technologies, Inc., PerkinElmer, Inc. (Horizon Discovery Ltd.), and Danaher Corporation (Integrated DNA Technologies), among others.
The key opportunities in the asthma spacers market include growing product adoption in emerging economies and rising awareness about asthma self-management. Additionally, new product launches catering to specific age groups can provide lucrative growth opportunities.
Technological advancements in asthma spacers like customized 3D-printed spacers, smart connected spacers, and portable peci-cut spacer devices are expected to boost the market growth over the forecast period.
Market drivers
Increasing prevalence of asthma globally is a major factor driving the growth of the asthma spacers market. As per WHO estimates, around 300 million people currently suffer from asthma worldwide. Moreover, rising pollution levels and growing allergens have contributed to the increasing incidence of asthma over the years. This is anticipated to propel the demand for effective asthma management devices like spacers over the forecast period.
Current Challenges in Asthma Spacers Market
There are several challenges being faced by the asthma spacers market currently. One of the major challenges is the lack of awareness regarding asthma spacers among a large section of asthma patients. Many patients are still not aware of the benefits of using asthma spacers. Another key challenge is the preference for traditional inhalers over asthma spacers. Changing patient behavior and persuading them to opt for asthma spacers requires extensive education programs. Ensuring adherence to asthma treatment protocols is also a big task for healthcare professionals. Non-adherence to prescribed medication can worsen asthma symptoms.
SWOT Analysis
Strength: Asthma spacers are an effective and safer mode of asthma medication delivery compared to conventional inhalers. They help patients, especially children, properly coordinate actuation and inhalation.
Weakness: High cost of advanced asthma spacers is a limiting factor, especially in low and middle-income countries. Availability of generic alternatives also affects brand loyalty.
Opportunity: Growing geriatric population prone to respiratory illnesses presents an opportunity. Expanding availability of spacers compatible with various inhalers opens new markets.
Threats: Patent expiries of blockbuster respiratory drugs encourage generic competition. Stringent regulatory approvals for novel delivery devices delay market entry.
Geographical Regions with High Market Concentration
In terms of value, the asthma spacers market in North America accounts for the largest share, followed by Europe. This is attributed to the high prevalence of asthma, growing healthcare expenditure, presence of major players, and well-established healthcare and reimbursement policies in these regions.
Fastest Growing Geographical Region
Asia Pacific region is poised to witness the highest growth during the forecast period owing to increasing air pollution levels, growing awareness about asthma management, and improving access to healthcare facilities in emerging countries such as India and China. Rising medical tourism and presence of generic manufacturers in these nations will further support the regional market expansion.
